Literature DB >> 12911584

Prevalence and risk factors of non-fatal venous thromboembolism in the active population of the VITA Project.

A Tosetto1, M Frezzato, F Rodeghiero.   

Abstract

Cost-effective strategies for the identification of subjects at risk of venous thromboembolism (VTE) in the active population are still lacking. Our objectives were to identify risk factors for venous thromboembolism in active subjects. We analyzed data from a population-based sample of 15055 Caucasians aged 18-65 years randomly selected from the census list of the township of Vicenza, Italy. A validated methodology was used to retrospectively identify subjects with previous VTE. Body mass index (BMI), smoking, oral contraceptive use, previous superficial vein thrombophlebitis (SVT) and familial history of VTE, all at the age of first thrombosis, were ascertained by direct interview and by review of available medical records. Ninety-two deep vein thromboses [prevalence: 61.1/10000, 95% confidence interval (CI) 49.2-74.9], three upper deep vein thrombosis (prevalence: 1.9/10000, 95% CI 0.4-5.8) and 21 pulmonary embolism (prevalence: 13.9/10000, 95% CI 8.6-21.3) were identified. After age and sex adjustment, clinically identifiable risk factors were: history of SVT [odds ratio (OR) = 6.8], oral contraceptive use (OR = 4.7), family history of VTE (OR = 4.5), smoking (OR = 1.7) and BMI above the third tertile (OR vs. mid-tertile 2.9). While previous SVT and BMI were associated with VTE in all circumstantial situations (surgery/trauma, pregnancy or idiopathic VTE), for oral contraceptive use, positive family history and smoking the degree of association varied significantly depending on the situation. Non-fatal VTE affects 0.7% of the subjects belonging to an active population, 56% of cases being potentially preventable. In 30% of VTE cases, at least two easily recognizable risk factors are present. Clinical assessment of risk factors remains the mainstay of VTE prevention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911584     DOI: 10.1046/j.1538-7836.2003.00313.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting.

Authors:  Karin Hedenmalm; Eva Samuelsson
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

Review 4.  The Bariatric Patient in the Intensive Care Unit: Pitfalls and Management.

Authors:  Carlos E Pompilio; Paolo Pelosi; Melina G Castro
Journal:  Curr Atheroscler Rep       Date:  2016-09       Impact factor: 5.113

5.  Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study.

Authors:  Michael Spannagl; Lothar A J Heinemann; Thai Dominh; Anita Assmann; Wolfgang Schramm; Rolf Schürmann
Journal:  Thromb J       Date:  2005-07-20

6.  VTE Risk assessment - a prognostic Model: BATER Cohort Study of young women.

Authors:  Lothar Aj Heinemann; Thai Dominh; Anita Assmann; Wolfgang Schramm; Rolf Schürmann; Jan Hilpert; Michael Spannagl
Journal:  Thromb J       Date:  2005-04-18

Review 7.  Systematic reviews of observational studies of risk of thrombosis and bleeding in urological surgery (ROTBUS): introduction and methodology.

Authors:  Kari A O Tikkinen; Arnav Agarwal; Samantha Craigie; Rufus Cartwright; Michael K Gould; Jari Haukka; Richard Naspro; Giacomo Novara; Per Morten Sandset; Reed A Siemieniuk; Philippe D Violette; Gordon H Guyatt
Journal:  Syst Rev       Date:  2014-12-23

8.  Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort Study.

Authors:  Caroline Sindet-Pedersen; Louise Bruun Oestergaard; Anna Gundlund; Emil Loldrup Fosbøl; Kristian Aasbjerg; Jannik Langtved Pallisgaard; Gunnar Gislason; Christian Torp-Pedersen; Jonas Bjerring Olesen
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

9.  High rate of smoking in female patients with Mondor's disease in an outpatient clinic in Japan.

Authors:  Toshikatsu Okumura; Masumi Ohhira; Tsukasa Nozu
Journal:  Int J Gen Med       Date:  2012-09-04

Review 10.  Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.

Authors:  Yun-Jiu Cheng; Zhi-Hao Liu; Feng-Juan Yao; Wu-Tao Zeng; Dong-Dan Zheng; Yu-Gang Dong; Su-Hua Wu
Journal:  PLoS Med       Date:  2013-09-17       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.